The Immunomodulatory Effects of Statins on Macrophages

The Immunomodulatory Effects of Statins on Macrophages

Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors used worldwide to manage dyslipidaemia and thus limit the development of atherosclerotic disease and its complications. These atheroprotective drugs are now known to exert pleiotropic actions outside of their cholestero...

Full description

Bibliographic Details
Main Authors:	Alanah Sheridan, Caroline P. D. Wheeler-Jones, Matthew C. Gage
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Immuno
Subjects:	statins macrophages atherosclerosis inflammation cholesterol atorvastatin
Online Access:	https://www.mdpi.com/2673-5601/2/2/21

Similar Items

Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy
by: Allison B. Reiss, et al.
Published: (2019-08-01)

Hypolidemic therapy today. New challenges and opportunities of statines
by: V. P. Mikhin, et al.
Published: (2018-04-01)

Modern statin therapy in clinical practice: The lower the better
by: Stokić Edita
Published: (2013-01-01)

Inhibition of EphA2 protects against atherosclerosis by synergizing with statins to mitigate macrophage inflammation
by: Jie Zeng, et al.
Published: (2023-12-01)

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE
by: A. V. Susekov, et al.
Published: (2016-01-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
by: Homa Nomani, et al.
Published: (2021-02-01)

Atherosclerosis, cholesterol, nutrition, and statins – a critical review
by: Gebbers, Jan-Olaf
Published: (2007-08-01)

Cerebrovascular Disease and Statins
by: Luis M. Beltrán Romero, et al.
Published: (2021-12-01)

Peripheral polyneuropathy in patients receiving long-term statin therapy
by: Ibrahim Halil Özdemir, et al.
Published: (2019-10-01)

Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
by: Enrica Rossini, et al.
Published: (2022-08-01)

Statins Directly Influence the Polarization of Adipose Tissue Macrophages: A Role in Chronic Inflammation
by: Sona Kauerova, et al.
Published: (2021-02-01)

Statin-induced necrotizing autoimmune myopathy: a systematic review
by: Manoj Reddy Somagutta, et al.
Published: (2022-02-01)

Are statins anti-inflammatory?
by: Ridker Paul M, et al.
Published: (2000-11-01)

Atorvastatin blocks Sonic Hedgehog medulloblastoma progression through apoptosis
by: R.E. Gordon, et al.
Published: (2017-12-01)

ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE
by: N. G. Gogolashvili
Published: (2018-03-01)

RELEVANCY OF HIGH DOSE STATINS APPLICATION BEFORE AND AFTER MYOCARDIUM REVASCULARIZATION
by: M. V. EZHOV
Published: (2016-12-01)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)

Development of Human‐Like Advanced Coronary Plaques in Low‐Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques
by: Yuxin Li, et al.
Published: (2016-04-01)

COVID-19 and Thromboinflammation: Is There a Role for Statins?
by: Filipe Ferrari, et al.

Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01)

Pro-efferocytosis biomimetic nanocomplexes for targeted atherosclerosis therapy through promoting macrophage re-polarization and inhibiting senescence
by: Peidong You, et al.
Published: (2023-10-01)

New insights into the therapeutic potentials of statins in cancer
by: Chengyu Liu, et al.
Published: (2023-07-01)

Rac GTPase Signaling in Immune-Mediated Mechanisms of Atherosclerosis
by: Cadence F. Lee, et al.
Published: (2021-10-01)

Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma
by: Jiao Wang, et al.
Published: (2024-02-01)

Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
by: Saeed Kalantari, et al.
Published: (2014-01-01)

Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside
by: Marko Kumric, et al.
Published: (2023-04-01)

Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
by: Piotr Fularski, et al.
Published: (2023-06-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trialResearch in context
by: Seung-Jun Lee, et al.
Published: (2023-10-01)

Effects of Statins on Gut Microbiota (Microbiome)
by: Milad Ashrafizadeh, et al.
Published: (2019-06-01)

Statin induced regression of cardiomyopathy trial: A randomized, placebo-controlled double-blind trial
by: Ahmad Hersi, et al.
Published: (2016-01-01)

Statins and diabetes: focus on pitavastatin
by: Soreiia A. Urazgildeeva
Published: (2020-09-01)

Statin Prescription Patterns and Associations with Subclinical Inflammation
by: Preetham Kadappu, et al.
Published: (2022-08-01)

Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
by: Roberta Filipini Rampelotto, et al.
Published: (2018-07-01)

COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE
by: S. V. Shalaev, et al.
Published: (2016-01-01)

Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review
by: Manuel Blonç, et al.
Published: (2023-02-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

Statins in the treatment and the prevention of the progression of atherosclerosis of patients with coronary heart disease
by: T. E Morozova, et al.
Published: (2013-03-01)

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023-12-01)